1. Home
  2. EVO vs CUBI Comparison

EVO vs CUBI Comparison

Compare EVO & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • CUBI
  • Stock Information
  • Founded
  • EVO 1993
  • CUBI 1994
  • Country
  • EVO Germany
  • CUBI United States
  • Employees
  • EVO N/A
  • CUBI N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • CUBI Major Banks
  • Sector
  • EVO Health Care
  • CUBI Finance
  • Exchange
  • EVO Nasdaq
  • CUBI Nasdaq
  • Market Cap
  • EVO 1.5B
  • CUBI 1.5B
  • IPO Year
  • EVO 2021
  • CUBI 2012
  • Fundamental
  • Price
  • EVO $4.11
  • CUBI $49.99
  • Analyst Decision
  • EVO Buy
  • CUBI Buy
  • Analyst Count
  • EVO 2
  • CUBI 9
  • Target Price
  • EVO $5.90
  • CUBI $63.88
  • AVG Volume (30 Days)
  • EVO 184.0K
  • CUBI 366.5K
  • Earning Date
  • EVO 11-06-2024
  • CUBI 01-27-2025
  • Dividend Yield
  • EVO N/A
  • CUBI N/A
  • EPS Growth
  • EVO N/A
  • CUBI N/A
  • EPS
  • EVO N/A
  • CUBI 6.16
  • Revenue
  • EVO $866,665,179.00
  • CUBI $672,806,000.00
  • Revenue This Year
  • EVO $3.89
  • CUBI N/A
  • Revenue Next Year
  • EVO $9.65
  • CUBI $8.13
  • P/E Ratio
  • EVO N/A
  • CUBI $8.12
  • Revenue Growth
  • EVO N/A
  • CUBI 9.04
  • 52 Week Low
  • EVO $2.85
  • CUBI $42.31
  • 52 Week High
  • EVO $8.39
  • CUBI $68.49
  • Technical
  • Relative Strength Index (RSI)
  • EVO 42.87
  • CUBI 52.87
  • Support Level
  • EVO $4.00
  • CUBI $44.69
  • Resistance Level
  • EVO $4.63
  • CUBI $50.15
  • Average True Range (ATR)
  • EVO 0.14
  • CUBI 1.66
  • MACD
  • EVO -0.04
  • CUBI 0.34
  • Stochastic Oscillator
  • EVO 16.88
  • CUBI 88.78

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.

Share on Social Networks: